|
2023 Paper for IPO Software and Medical Device Subcommittee
|
April 19, 2024 |
IPO Law Journal |
|
IPOwners Quarterly™ 4/17/2024
|
April 19, 2024 |
IPOwners Quarterly |
|
Brazil: Hot Topics in IP during 2023
|
April 15, 2024 |
IPO Law Journal |
|
FEDERAL CIRCUIT UPHOLDS DETERMINATION OF UNCLEAN HANDS* *
Luv N’ Care, Ltd. v. Laurain, 22-1905, 22-1970
|
April 12, 2024 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT FINDS REASONABLE EXPECTATION OF SUCCESS IN RIFAXIMIN DOSAGE*
Salix Pharms., Ltd. v. Norwich Pharms. Inc., 22-2153, 23-1952
|
April 11, 2024 |
IPO Federal Circuit Summaries |
|
CLAIMS FOR ASSESSING AND VIEWING MEDICAL SCANS ONLINE WERE PATENT-INELIGIBLE*
AI Visualize, Inc. v. Nuance Commc’ns, Inc., 22-2109
|
April 04, 2024 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT VACATES DISTRICT COURT NONOBVIOUSNESS DECISION FOR MISCONSTRUING SCOPE OF CLAIMS*
Janssen Pharm., Inc. v. Teva Pharm. USA, Inc. – 22-1258, 22-1307
|
April 01, 2024 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT VACATES INVALIDITY JUDGMENT DUE TO FAULTY JURY INSTRUCTIONS ON OBJECTIVE INDICIA OF NONOBVIOUSNESS*
Inline Plastics Corp. v. Lacerta Group, LLC, 22-1954, 22-2295
|
March 27, 2024 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT PROPERLY EXCLUDED DAMAGES THEORY* *
Brumfeld v. IBD, LLC, 22-1630
|
March 27, 2024 |
IPO Federal Circuit Summaries |
|
PTAB OBVIOUSNESS DECISION OVERTURNED FOR LACK OF EVIDENCE OF MOTIVATION TO COMBINE*
Virtek Vision Int’l ULC v. Assembly Guidance Sys., Inc., 22-1998, 22-2022
|
March 27, 2024 |
IPO Federal Circuit Summaries |
|
IMPORTATION OF HEART VALVE SYSTEMS “REASONABLY RELATED TO FDA APPROVAL” FELL UNDER Section 271(E)(1)’S SAFE HARBOR* *
Edwards Lifesciences Corp. v. Meril Life Sciences PVT., 22-1877
|
March 25, 2024 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT OVERTURNS DISTRICT COURT JUDGMENT THAT CLAIMS WERE INDEFINITE* *
Maxell, Ltd. v. Amperex Technology Ltd., 23-1194
|
March 06, 2024 |
IPO Federal Circuit Summaries |
|
USPTO PROPERLY CANCELED VACCINE CLAIMS AS OBVIOUS BASED ON “RESULT-EFFECTIVE VARIABLE DOCTRINE”* *
Pfizer Inc. v. Sanofi Pasteur Inc., 19-1871
|
March 05, 2024 |
IPO Federal Circuit Summaries |
|
CLAIMS FOR TARGETING WEB-BASED ADS WERE PATENT INELIGIBLE*
Chewy, Inc. v. IBM, 22-1756
|
March 05, 2024 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT UPHOLDS FINDING OF NO INEQUITABLE CONDUCT*
Freshub, Inc. v. Amazon.Com, Inc., 22-1391
|
February 26, 2024 |
IPO Federal Circuit Summaries |
|
AI Patenting Handbook
|
February 20, 2024 |
IPO Law Journal |
|
FEDERAL CIRCUIT PROHIBITS INCORPORATION OF MATERIAL BY REFERENCE THAT WOULD EXCEED WORD COUNT*
Promptu Systems Corporation v. Comcast Corporation, 22-1093
|
February 16, 2024 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT VACATES DISTRICT COURT’S CLAIM CONSTRUCTIONS*
Promptu Systems Corporation v. Comcast Corporation, 22-1939
|
February 16, 2024 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT VACATES USPTO DISMISSAL OF PETITION TO CANCEL TRADEMARK REGISTRATION* *
Naterra Int’l, Inc. v. Bensalem, 22-1872
|
February 15, 2024 |
IPO Federal Circuit Summaries |
|
USPTO’S “DOMICILE ADDRESS REQUIREMENT” FOR TRADEMARK APPLICATIONS DOES NOT VIOLATE APA*
In Re: Chestek PLLC, 22-1843
|
February 13, 2024 |
IPO Federal Circuit Summaries |
|
SUBSTANTIAL EVIDENCE DID NOT SUPPORT USPTO’S PGR DECISION THAT CLAIMS LACKED WRITTEN DESCRIPTION SUPPORT UNDER SECTION 112*
RAI Strategic Holdings, Inc. v. Philip Morris Products S.A., 22-1862
|
February 09, 2024 |
IPO Federal Circuit Summaries |
|
COURT REVERSES IPR DETERMINATION THAT MANUALS WERE NOT PRINTED PUBLICATIONS*
Weber, Inc. v. Provisur Technologies, Inc., 22-1751
|
February 08, 2024 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT OVERTURNS IPR DECISION BASED ON ERRONEOUS CLAIM CONSTRUCTION*
Google LLC v. EcoFactor, Inc., 22-1750
|
February 07, 2024 |
IPO Federal Circuit Summaries |
|
IPO Comments on Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights
|
February 06, 2024 |
Testimony and Comments |
|
IPO Comments Regarding FTC’s Petition for Rulemaking of PIRG and iFixit
|
February 02, 2024 |
Testimony and Comments |
|
IPO 2024 Special 301 Review Comments
|
January 30, 2024 |
Testimony and Comments |
|
IPO’s Notice of Intent to Testify and Hearing Statement re: 2024 Special 301
|
January 30, 2024 |
Testimony and Comments |
|
IPO’s Comments to Department of Health and Human Services Re: Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement
|
January 29, 2024 |
Testimony and Comments |
|
FEDERAL CIRCUIT UPHOLDS REFUSAL TO REGISTER TRADEMARK*
In re GO & Associates, LLC, 22-1961
|
January 22, 2024 |
IPO Federal Circuit Summaries |
|
IPO Comments to USPTO on WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge
|
January 22, 2024 |
Testimony and Comments |
|
FEDERAL CIRCUIT UPHOLDS ITC DECISION FINDING SECTION 337 VIOLATION*
Roku, Inc. v. ITC, 22-1386
|
January 19, 2024 |
IPO Federal Circuit Summaries |
|
2023 Top 300 Patent Owners
|
January 19, 2024 |
Top 300 Patent Owners |
|
OPPOSITION TO MOTION TO AMEND CLAIMS WAS PROPERLY ALLOWED IN IPR PROCEEDING*
CyWee Group Ltd. v. ZTE (USA), Inc., 21-1855
|
January 18, 2024 |
IPO Federal Circuit Summaries |
|
USPTO MAY NOT CANCEL TRADEMARK REGISTRATION BASED ON FRAUDULENT DECLARATION MADE TO ACQUIRE INCONTESTABLE STATUS* *
Great Concepts, LLC v. Chutter, Inc., 22-1212
|
January 10, 2024 |
IPO Federal Circuit Summaries |
|
USPTO CORRECTLY CONSTRUED CLAIMS IN IPR*
Pacific Biosciences of California, Inc. v. Personal Genomics Taiwan, Inc., 22-1410
|
January 09, 2024 |
IPO Federal Circuit Summaries |
|
IPRS NOT BARRED BY FORUM SELECTION CLAUSE*
DexCom, Inc. v. Abbott Diabetes Care, Inc., 23-1795
|
January 03, 2024 |
IPO Federal Circuit Summaries |
|
ERRONEOUS CLAIM CONSTRUCTION RESULTED IN REVERSAL OF SUMMARY JUDGMENT OF NON-INFRINGEMENT*
K-fee System GmbH v. Nespresso USA, 2022-2042
|
December 26, 2023 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT UPHOLDS USPTO CLAIM CONSTRUCTION THAT CONFLICTED WITH DISTRICT COURT’S IN PARALLEL LITIGATION*
ParkerVision, Inc. v. Vidal, 22-1548
|
December 15, 2023 |
IPO Federal Circuit Summaries |
|
Boosting Brazil’s Semiconductor Industry: BRPTO’s Active Participation and Government Initiatives
|
December 08, 2023 |
IPO Law Journal |
|
PATENT NOT INFRINGED BY GENERIC FIRM’S FILING APPLICATION TO MARKET DRUG FOR USE NOT CLAIMED IN PATENTS* *
H. Lundbeck A/S v. Lupin Ltd., 22-1194
|
December 07, 2023 |
IPO Federal Circuit Summaries |